SUBSCRIBE
SUBSCRIBE

Fibrobiologics

IN THE PRESS
Press Releases
FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting
March 24, 2025
 · 
2 min read
Press Releases
FibroBiologics Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-based Therapeutics
March 4, 2025
 · 
4 min read
Press Releases
FibroBiologics and Charles River Announce Completion and Release of CYWC628 Master Cell Bank for the Manufacturing of Fibroblast Cell-based Wound Healing Therapeutic
February 27, 2025
 · 
5 min read
Press Releases
FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates
February 5, 2025
 · 
1 min read
Press Releases
FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing
December 31, 2024
 · 
4 min read
Press Releases
FibroBiologics Announces $25 Million Financing
December 23, 2024
 · 
4 min read
Press Releases
FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly
November 20, 2024
 · 
4 min read
Press Releases
FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics
November 14, 2024
 · 
4 min read
Press Releases
FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
November 13, 2024
 · 
7 min read
Press Releases
FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology
October 29, 2024
 · 
5 min read
Load More
JOBS